Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

被引：0
|
作者：
Berntorp, Erik [1 ]
Abshire, Thomas C. [2 ]
Federici, Augusto B. [3 ]
机构：
[1] Lund Univ, Malmo Ctr Thrombosis & Haemostasis, Malmo, Sweden
[2] Blood Ctr Wisconsin, Milwaukee, WI USA
[3] Univ Milan, Dept Internal Med, Milan, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：109 / 110
页数：2
相关论文
共 50 条
  • [31] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Sidonio Jr, Robert F.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Boda, Zoltan
    Lissitchkov, Toshko
    Nemes, Laszlo
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia Djambas
    BLOOD ADVANCES, 2024, 8 (06) : 1405 - 1414
  • [32] Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor
    Peyvandi, Flora
    Kouides, Peter
    Turecek, Peter L.
    Dow, Edward
    Berntorp, Erik
    BLOOD REVIEWS, 2019, 38
  • [33] Bleeding in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)
    Weyand, Angela C.
    Chandler, Martin
    Fedor, Carol
    Friedman, Kenneth D.
    Gupta, Sweta
    Haley, Kristina M.
    He, Chunla
    Hirsh, Nikki
    Pels, Salley
    Roberts, Jonathan C.
    Wynn, Tung T.
    Sidonio, Robert F., Jr.
    BLOOD, 2021, 138
  • [34] CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A VON WILLEBRAND FACTOR FVIII CONCENTRATE (VWF/FVIII) DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD)
    Sidonio, R.
    Dubey, L.
    Timofeeva, M.
    Vilchevska, K.
    Vdovin, V.
    Schmid, M.
    Solomon, C.
    Knaub, S.
    HAEMOPHILIA, 2020, 26 : 140 - 140
  • [35] Severe von Willebrand disease (VWD) in pregnancy and childbirth: a case series
    Malina, M.
    Abdul-Kadir, R.
    Pollard, D.
    Siebert, M.
    Halimeh, S.
    THROMBOSIS RESEARCH, 2015, 135 : S83 - S83
  • [36] The role of prophylaxis in the management of von Willebrand disease: today and tomorrow
    Abshire, Thomas
    THROMBOSIS RESEARCH, 2009, 124 : S15 - S19
  • [37] Prophylaxis in patients with von Willebrand disease: who, when, how?
    Federici, A. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (09) : 1581 - 1584
  • [38] RETROSPECTIVE REVIEW OF FOUR DAYS OF VON WILLEBRAND'S FACTOR AS SURGICAL PROPHYLAXIS IN VON WILLEBRAND'S DISEASE
    Bal, S.
    Riaz, M. K.
    Peters, D.
    Palascak, J.
    Girnius, S.
    HAEMATOLOGICA, 2017, 102 : 401 - 402
  • [39] Study of human von Willebrand factor immunogenicity in pigs with severe von Willebrand disease
    Sauger, A
    Chtourou, S
    Samor, B
    Bonneau, M
    Roussi, J
    Drouet, L
    Mazurier, C
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (03) : 187 - 192
  • [40] Quality of Life in Patients with Clinically Severe Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe Von Willebrand Disease (VWD)
    Weyand, Angela C.
    Chandler, Martin
    Fedor, Carol
    Recht, Michael
    Sidonio, Robert F., Jr.
    BLOOD, 2022, 140 : 5600 - 5602
12345